{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:58:48Z","timestamp":1760230728362,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACyT), Mexico","award":["289788","A1-S-18342"],"award-info":[{"award-number":["289788","A1-S-18342"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Despite the high number of vaccines administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, the information on the psychological\/psychiatric adverse events following immunization (AEFI) with these newly developed vaccines remains scarce. Objective: To describe the frequency of psychological\/psychiatric symptoms among recipients of five different anti-SARS-CoV-2 vaccines and to explore the factors associated with their development reported in the nationwide Mexican registry of AEFI against SARS-CoV-2. Methods: Descriptive study of all the psychological\/psychiatric symptoms, including anxiety, panic attacks, insomnia, and agitation reported to the Mexican Epidemiological Surveillance System from 21 December 2020 to 27 April 2021, among adult (\u226518 years old) recipients of 7,812,845 doses of BNT162b2, ChAdOx1 nCov-19, rAd26-rAd5, Ad5-nCoV, or CoronaVac. The factors associated with their development are determined by multivariate regression analysis. Results: There were 19,163 AEFI reports during the study period; amongst them, 191 (1%) patients had psychological\/psychiatric symptoms (median age of 41 years, interquartile range of 32\u201354; 149 [78%] women) for an observed incidence of 2.44 cases per 100,000 administered doses (95% confidence interval [CI] 2.12\u20132.82), 72.8% of psychiatric AEFIs were reported among recipients of BNT162b2. The median time from vaccination to symptom onset was 35 min (interquartile range: 10\u2013720). Overall, the most common psychological\/psychiatric symptoms were anxiety in 129 (67.5%) patients, panic attacks in 30 (15.7%), insomnia in 25 (13%), and agitation in 11 (5.7%). After adjusting for the confounding factors, the odds for developing psychological\/psychiatric symptoms were higher for those concurrently reporting syncope (odds ratio [OR]: 4.73, 95% CI: 1.68\u201313.33); palpitations (OR: 2.47, 95% CI: 1.65\u20133.70), and dizziness (OR: 1.59, 95% CI: 1.10\u20132.28). Conclusion: In our population, psychological\/psychiatric symptoms were extremely infrequent AEFIs. No severe psychiatric AEFIs were reported. Immunization stress-related responses might explain most of the detected cases.<\/jats:p>","DOI":"10.3390\/vaccines10081297","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:05:49Z","timestamp":1660259149000},"page":"1297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2"],"prefix":"10.3390","volume":"10","author":[{"given":"Mario","family":"Garc\u00eda-Alanis","sequence":"first","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-8387","authenticated-orcid":false,"given":"Marisa","family":"Morales-C\u00e1rdenas","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1218-1721","authenticated-orcid":false,"given":"Liz Nicole","family":"Toapanta-Yanchapaxi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-295X","authenticated-orcid":false,"given":"Erwin","family":"Chiquete","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-9115","authenticated-orcid":false,"given":"Isaac","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santa Elizabeth","family":"Ceballos-Liceaga","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Epidemiolog\u00eda, Secretar\u00eda de Salud, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Carbajal-Sandoval","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Epidemiolog\u00eda, Secretar\u00eda de Salud, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-2479","authenticated-orcid":false,"given":"Carla","family":"Toledo-Salinas","sequence":"additional","affiliation":[{"name":"Comisi\u00f3n Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Mexico City 14610, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-7136","authenticated-orcid":false,"given":"David Alejandro","family":"Mendoza-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Pediatr\u00eda, Mexico City 04530, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-5721","authenticated-orcid":false,"given":"Selma Cecilia","family":"Scheffler-Mendoza","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Pediatr\u00eda, Mexico City 04530, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Ortega-Martell","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca 42039, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Armando","family":"Carrillo-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Epidemiolog\u00eda, Secretar\u00eda de Salud, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-6366","authenticated-orcid":false,"given":"No\u00e9","family":"Hern\u00e1ndez-Valdivia","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Epidemiolog\u00eda, Secretar\u00eda de Salud, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso","family":"Guti\u00e9rrez-Romero","sequence":"additional","affiliation":[{"name":"Department of Neurology, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez, Mexico City 14269, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Andr\u00e9s","family":"Galnares-Olalde","sequence":"additional","affiliation":[{"name":"Department of Neurology, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez, Mexico City 14269, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-3565","authenticated-orcid":false,"given":"Fernando Daniel","family":"Flores-Silva","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"D\u00edaz-Ortega","sequence":"additional","affiliation":[{"name":"Centro Nacional para la Salud de la Infancia y la Adolescencia, Secretar\u00eda de Salud, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[{"name":"Comisi\u00f3n Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Mexico City 14610, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"L\u00f3pez-Gatell","sequence":"additional","affiliation":[{"name":"Secretar\u00eda de Salud, Gobierno de M\u00e9xico, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Cortes-Alcal\u00e1","sequence":"additional","affiliation":[{"name":"Secretar\u00eda de Salud, Gobierno de M\u00e9xico, Mexico City 01480, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Rogelio","family":"P\u00e9rez-Padilla","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas, Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-4138","authenticated-orcid":false,"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez, Mexico City 14269, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5287-1068","authenticated-orcid":false,"given":"Miguel","family":"Garc\u00eda-Grimshaw","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"},{"name":"Hospital General Tijuana, Tijuana 22000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-6484","authenticated-orcid":false,"given":"Sergio Iv\u00e1n","family":"Vald\u00e9s-Ferrer","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"},{"name":"Department of Infectious Diseases, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080, Mexico"},{"name":"Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"ref_1","unstructured":"(2021, December 22). COVID-19 Map\u2014Johns Hopkins Coronavirus Resource Center [Online]. Available online: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(20)30152-3","article-title":"Taking the right measures to control COVID-19","volume":"20","author":"Xiao","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","unstructured":"Secretar\u00eda de Salud, Gobierno de M\u00e9xico (2021, May 11). Pol\u00edtica Nacional Rectora de Vacunaci\u00f3n Contra el SARS-CoV-2 para la Prevenci\u00f3n de la COVID-19 en M\u00e9xico. Available online: http:\/\/vacunacovid.gob.mx\/wordpress\/wp-content\/uploads\/2021\/09\/2021.09.28-PNVx_COVID-1.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40249-021-00878-5","article-title":"Safety of SARS-CoV-2 vaccines: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Chen","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.vaccine.2020.02.046","article-title":"Immunization stress-related response\u2014Redefining immunization anxiety-related reaction as an adverse event following immunization","volume":"38","author":"Gold","year":"2020","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2021.10.058","article-title":"Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study","volume":"39","year":"2021","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2017.11.017","article-title":"Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness","volume":"36","author":"Loharikar","year":"2018","journal-title":"Vaccine"},{"key":"ref_10","first-page":"e1933","article-title":"Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study","volume":"98","year":"2022","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","article-title":"Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine","volume":"230","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Grimshaw, M., Galnares-Olalde, J.A., Bello-Chavolla, O.Y., Michel-Ch\u00e1vez, A., Cadena-Fern\u00e1ndez, A., Brise\u00f1o-God\u00ednez, M.E., Antonio-Villa, N.E., N\u00fa\u00f1ez, I., Guti\u00e9rrez-Romero, A., and Hern\u00e1ndez-Vanegas, L. (2022). Incidence of Guillain-Barr\u00e9 Syndrome Following SARS-CoV-2 Immunization: Analysis of a Nationwide Registry of Recipients of 81 Million Doses of Seven Vaccines. Eur. J. Neurol., ene.15504.","DOI":"10.1111\/ene.15504"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.1016\/j.clim.2021.108786","article-title":"Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study","volume":"229","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable Inference, the Law of Succession, and Statistical Inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2021.36.e115","article-title":"Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea","volume":"36","author":"Bae","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"601170","DOI":"10.3389\/fimmu.2020.601170","article-title":"Sex Differences in Immunity: Implications for the Development of Novel Vaccines against Emerging Pathogens","volume":"11","author":"Fathi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.vaccine.2021.04.066","article-title":"Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines","volume":"39","author":"Somiya","year":"2021","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Green, M.S., Peer, V., Magid, A., Hagani, N., Anis, E., and Nitzan, D. (2022). Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine. Vaccines, 10, Available online: https:\/\/www.mdpi.com\/2076-393X\/10\/2\/233.","DOI":"10.3390\/vaccines10020233"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"604000","DOI":"10.3389\/fimmu.2020.604000","article-title":"Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics","volume":"11","author":"Shepherd","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US\u201414 December 2020\u201318 January 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/WCO.0000000000000809","article-title":"Persistent inflammatory states and their implications in brain disease","volume":"33","author":"Benkendorff","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000513968","article-title":"The Role of Illness Behavior in the COVID-19 Pandemic","volume":"90","author":"Cosci","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000343508","article-title":"The Unifying Concept of Illness Behavior","volume":"82","author":"Sirri","year":"2013","journal-title":"Psychother. Psychosom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1080\/21645515.2021.1924017","article-title":"COVID-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India","volume":"17","author":"Panda","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"698111","DOI":"10.3389\/fpubh.2021.698111","article-title":"Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review","volume":"9","author":"Joshi","year":"2021","journal-title":"Front. Public Health"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Alshurman, B.A., Khan, A.F., Mac, C., Majeed, M., and Butt, Z.A. (2021). What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18179342"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Biswas, M.R., Alzubaidi, M.S., Shah, U., Abd-Alrazaq, A.A., and Shah, Z. (2021). A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants. Vaccines, 9.","DOI":"10.3390\/vaccines9111243"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Marco-Franco, J.E., Pita-Barros, P., Vivas-Orts, D., Gonz\u00e1lez-De-Juli\u00e1n, S., and Vivas-Consuelo, D. (2021). COVID-19, Fake News, and Vaccines: Should Regulation Be Implemented?. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18020744"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"774504","DOI":"10.3389\/fpsyt.2021.774504","article-title":"COVID-19 Vaccine-Related Psychological Stress among General Public in China","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14760584.2015.964212","article-title":"Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications","volume":"14","author":"Vivion","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1080\/10410236.2020.1838096","article-title":"Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence","volume":"35","author":"Chou","year":"2020","journal-title":"Health Commun."},{"key":"ref_33","unstructured":"Causality Assessment of an Adverse Event Following Immunization (AEFI): User Manual for the Revised WHO Classification, [2nd ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/causality-assessment-aefi-user-manual-2019."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jan.13818","article-title":"The fear of needles: A systematic review and meta-analysis","volume":"75","author":"McLenon","year":"2019","journal-title":"J. Adv. Nurs."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.14745\/ccdr.v46i06a10","article-title":"Managing immunization stress-related response: A contributor to sustaining trust in vaccines","volume":"46","author":"McMurtry","year":"2020","journal-title":"Can. Commun. Dis. Rep."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:07Z","timestamp":1760141227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["vaccines10081297"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10081297","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}